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Introduction

48
Coronary artery disease (CAD) is the formation of plaques in the interior of the coronary 49 vessel walls. This condition often leads to thrombus related complications that make CAD 50 the leading cause or mortality worldwide [1] . Thrombus formation in coronary artery . is 51 believed to be triggered by the rupture of an atheromatous plaque and subsequent 52 exposure of tissue factor (TF) and collagen. The triggering is followed by a series of 53 biochemical reactions that result in the activation of fibrin by thrombin and the formation of 54 the clot that narrows or blocks the flow in the coronary artery. As some of these reactions 55 occur much faster on the membrane of platelets and endothelium cells the contemporary 56 description of the process is cell-based [7] . Intracoronary ultrasound findings have suggested 57 that a ruptured plaque does not necessary lead to thrombosis [3] [4] [5] . This can be attributed to 58 any of the three factors, traditionally known as Virchow's triad, that influence the process: 59
(1) specific conditions on vessel's wall (2) coagulability of blood and (3) local flow conditions 60 [2] . 61
. During the last three decades, there were several attempts to investigate aspects of the 62 process of thrombus formation using computational simulations. Based on in-vitro 63 experiments on the enzymatic reactions (indicatively [12] ) zero-dimensional models that 64
reproduce the temporal evolution of the coagulation system have been developed., The first 65 model consisted of 14 reaction rate constants, describing the activation and inhibition of 66 four coagulation factors [13] , while following works included up to 50 constants and focused 67 on the extrinsic [14, 15] platelet aggregation, could also fit into this category [23] . While there are recent works using 76 simplified reaction models, [24] . the trend is towards more complicated multi-scale and 77 multi-phase models. These models, in addition to the set of equations that represents the 78 reactions, may incorporate the movement of cells, the localization of equations and the 79 change of blood properties due to blood clotting. Kuharsky and Fogelson [25] proposed an 80 integrated model for thrombin generation under a simplified flow field, using a system of 59 81 equations that also included the binding of substances and the localization of reactions on 82 surfaces. . In following publications by the same group additional processes were 83 incorporated in the model:the alteration of the rheological properties of blood due to 84 clotting, by modelling platelet-platelet and platelet-wall interaction as reversible elastic 85 links. [26] . ;the APC mechanism and the transport of substances between plasma and 86 endothelium cells [27] . Additionally, a small scale discrete model using an immersed 87 presented another multi-process model that used a viscoelastic model to simulate flow for 99 both free vessel lumen and clot. This model also incorporated the activation of platelets due 100 to excessive shear stress and fibrin production and lysis. In a similar work, a model for the 101 viscosity of blood depending on fibrin concentration was proposed and used in a three-102 dimensional simulation of blood coagulation in a tube [37] . 103
For the case of coronary thrombosis, a typical value for the diameter of the artery is around 104 4mm and the flow is strongly three-dimensional and time dependent, preventing utilization 105 of simplified flow fields. Additionally there is significant variability of the response of the 106 coagulation system observed for different individuals [38] . From the reviewed works, only 107 the latest was applied on 3D geometries, while the typical used regions are 2D simplified 108 geometries with dimensions of 100×100μm 2 .In most studies the flow field is simplified and 109 predefined. Finally, the inclusion of a large number of processes makes the application of 110 the models computationally expensive while at the same time they require a large amount 111 of experimental data in order to be adapted for different patients. Due to these limitations 112 of the existing methods there is no connection between modelling of thrombus formation 113 and clinical practice. 114
In this work, we propose a model for coagulation under realistic flow conditions up to the 115 stage of thrombin generation that compensates for some of these difficulties. The proposed 116 phenomenological model has the following characteristics: (1) computational effectiveness, 117 so that it can be coupled with transient flow simulations; (2) ability to obtain patient specific 118 character in a manner that can be directly related to clinical practice, drawing data directly 119 from clinical tests. 120
Materials and methods
121
Thrombus modelling 122
For the description of the coagulation process the cell based approach ( Figure 1 
Coupling with flow 150
For the simulations including flow, the concentrations of the blood circulating species 151
were calculated using the convection-diffusion equation with source terms (S i ) (equation 1). 152
For immobilized species ( ) the source term expresses the temporal evolution (equation 153 2). 154
Equation 1 155
Equation 2 156 The quantity of bound species is expressed in surface concentration (kg/m 2 ), while the 157 circulating species in volume concentration (kg/kg). In the reactions involving transition of a 158 species from circulating to bound state and vice versa the actual mass of the involved 159 species in the computational cell is calculated, using the volume of the computational cell or 160 the reacting surface. Then the fraction of the species that is binding or unbinding is 161 computed using the appropriate reaction rate constant. A number of sub-threshold setups were also simulated to test the behaviour of the model 228 (Table 1) . As the initiation was considered a surface reaction, the threshold condition for the 229 transition from the initiation to the amplification phase was also modified and was 230 expressed as amount of thrombin per surface unit 231 instead of being expressed as volume concentration (1.2nM). This modification implies that 232 the initiation occurs in a reaction zone of approximately 3μm above the reacting surface. 233
This approach also enforces the mesh independence of the model. As the surface thrombin 234 generation is proportional to the reacting surface, using a transition criterion based on the 235 volume concentration of thrombin would lead to strong dependence of the transition on the 236 volume of the computational cell. The simulations also revealed that from the wall shear 237 rate value ( ) and the stream-wise length of the reacting area ( ), we can derive a 238 quantity, previously defined as coagulation activation index [42] , that is 239 related to the initiation of coagulation. CAI is proportional to the residence time of the blood 240 components over the reacting surface. As shown in Table 1 not presented were simulated in order to confirm that SA and SB were actually 247 threshold setups for the initiation and that a small modification of the parameters to 248 the direction of reduced CAI does not allow initiation. 249
The platelet aggregation model was tested for the three different flow conditions described 250 in the simulated experiment. The experimental results of platelet aggregation regarding the 251 maximum amount of bound platelets and the initial aggregation rate were accurately 252 approximated by the simulations as shown in Figure 6 . The model failed to predict the 253 disaggregation of platelets that was observed in high shear rate conditions after 10 min of 254 perfusion. However this happens more likely due to stress accumulation as the aggregate is 255 continuously subject to high shear stress values (1690s -1 ) while for the transient coronary 256 flow used in this study the average wall shear rate is much lower (235s -1 ). 257
For the two sets of simulations described above, the flow field was obtained by solving the 258 incompressible Navier-Stokes equations in FLUENT ANSYS, while fixed mass flowrates were 259 used for both the inlet and the outlet of computational domain. As the interaction between 260 flow and biochemical reactions is not considered, the biochemical models were applied on 261 steady predefined flow field. In MI1 and STA geometries, the transition from initiation to amplification phase was fast and 278 levels of thrombin concentration that are considered sufficiently high to cause platelet 279 activation (>1.2nM) were present downstream the reacting area only after the amplification. 280
In these models the downstream propagation was observed after the initiation phase. In 281 MI2 geometry the process had much slower progress and while in specific points 282 downstream the reacting surface thrombin exceeds the threshold value during the initiation 283 phase. The simulations were stopped 2 minutes after the downstream propagation and after 284 maximum thrombin concentration had obtained a constant value, approximately 1.5 285 minutes after the downstream propagation. In all cases the process was limited in a small 286 zone near the vessel wall, even in the presence of vortices. 287
The difference in the temporal evolution is caused by the different distribution of bound 288 activated platelets on the reacting surface of the vessel wall (Figure 8 ). While the total 289 amount increases in a similar manner for all three geometries, in MI1 and STA geometry 290 there is a small area at the end of the reacting boundary where the amount of bound 291 activated platelets is more than one order of magnitude higher than the average. On the 292 contrary, in MI2 geometry activated platelets are uniformly distributed on the reacting 293 surface and this has as a result a prolonged initiation phase and a large amount of activated 294 platelets at the instance of the transition to the amplification phase. This large amount of 295 bound activated platelets in MI2 geometry explains the observation of above threshold 296 (>1.2nM) thrombin concentration before the main amplification phase. 297 These bound platelets will become activated during the propagation phase and contribute 335 locally to thrombin generation. The observed mechanism indicates that it is very possible 336 that the prolonged lag phase indicates increased risk for thrombotic complications in vivo, 337
provided that an initiation stimulus is present a fact that also supported by recent clinical 338 findings [51] . 339
It is interesting to note that while flow seems to have an important role, the whole process 340 of coagulation in LAD models was limited into a small boundary layer near the vessel wall. 341
The concentration of thrombin and activated platelets becomes approximately zero in a 342 small distance from the vessel wall. As Peclet number is too high (>10 4 ) even in a small 343 distance (~3μm) from the vessel wall, diffusion was not expected to have significant role 344 under arterial flow conditions but the restriction of coagulation products near the wall 345 occurs also in the areas where vortices are present. Therefore, according to our findings the 346 more important aspect of flow for coagulation is wall shear rate, while the possible 347 contribution of recirculation zones to the process was not confirmed by this work. 348
As the main concept in this work is the correlation of coagulation models with clinical tests, 349 in the future we intent to modify the proposed mathematical model for coagulation in a 350 manner that the platelet aggregation sub-model will be also calibrated based on existing 351 clinical platelet assays. We also intend to add the fibrin activation and polymerization part of 352 the process and correlate the model with thromboelastography tests (TEG). Finally, we also 353 hope, through partnership with a biochemical lab, to achieve in vitro quantitative validation 354 of the method by performing perfusion tests in coronary models. However, the findings of 355 this study indicate that it would be useful for clinical practice to co-estimate the prevailing 356 flow conditions and blood coagulability for each patient, and that this co-estimation can be 357 performed via numerical simulations. 358
Conclusions
359
In this study we proposed a method for modelling coagulation under flow up to thrombin 360 generation, based partly on clinical tests. We demonstrated that it is feasible to build a 361 coagulation model based on clinical tests instead of laboratory experiments and therefore 362 achieve a patient specific and more importantly clinically relevant simulation of blood 363 coagulation. The application of the model revealed that certain parameters that characterize 364 thrombin generation in TGA tests obtain different values for thrombin generation under 365 realistic flow conditions. Additionally, we showed that identical behaviour of blood can lead 366 to different temporal evolution of coagulation depending on the geometry of the coronary 367 and the flow conditions. As experiments in-vivo on coronary thrombosis are not feasible and 368 relative measurements are also extremely limited, the findings of this study demonstrate 369 that mathematical simulation of coagulation in a case specific manner is a promising and 370 inexpensive pathway towards the assessment of coronary disease and can contribute to the 371 prognosis of thrombotic complications. 372
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